These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 26616229)
1. Ki-67 labeling index can be used as a prognostic marker in gastrointestinal stromal tumor: a systematic review and meta-analysis. Pyo JS; Kang G; Sohn JH Int J Biol Markers; 2016 May; 31(2):e204-10. PubMed ID: 26616229 [TBL] [Abstract][Full Text] [Related]
2. Ki-67 labeling index may be a promising indicator to identify "very high-risk" gastrointestinal stromal tumor: a multicenter retrospective study of 1022 patients. Liu X; Qiu H; Zhang P; Feng X; Chen T; Li Y; Tao K; Li G; Sun X; Zhou Z; Hum Pathol; 2018 Apr; 74():17-24. PubMed ID: 28962945 [TBL] [Abstract][Full Text] [Related]
3. Meta-analysis of prognostic role of Ki-67 labeling index in gastric carcinoma. Pyo JS; Kim NY Int J Biol Markers; 2017 Oct; 32(4):e447-e453. PubMed ID: 28561880 [TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of PTEN, Ki-67 and CD44s expression patterns in gastrointestinal stromal tumors. Liang YM; Li XH; Li WM; Lu YY World J Gastroenterol; 2012 Apr; 18(14):1664-71. PubMed ID: 22529697 [TBL] [Abstract][Full Text] [Related]
5. Prognostic impact of gastrointestinal bleeding and expression of PTEN and Ki-67 on primary gastrointestinal stromal tumors. Wang H; Chen P; Liu XX; Zhao W; Shi L; Gu XW; Zhu CR; Zhu HH; Zong L World J Surg Oncol; 2014 Apr; 12():89. PubMed ID: 24712384 [TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of expressions of cell-cycle regulatory proteins in gastrointestinal stromal tumor and the relevance of the risk grade. Nakamura N; Yamamoto H; Yao T; Oda Y; Nishiyama K; Imamura M; Yamada T; Nawata H; Tsuneyoshi M Hum Pathol; 2005 Jul; 36(7):828-37. PubMed ID: 16084954 [TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical expression of p16INK4A, Ki-67, and Mcm2 proteins in gastrointestinal stromal tumors: prognostic implications and correlations with risk stratification of NIH consensus criteria. Huang HY; Huang WW; Lin CN; Eng HL; Li SH; Li CF; Lu D; Yu SC; Hsiung CY Ann Surg Oncol; 2006 Dec; 13(12):1633-44. PubMed ID: 17013685 [TBL] [Abstract][Full Text] [Related]
9. [Study on associated biomarkers influencing recurrence, metastasis and prognosis in patients with gastrointestinal stromal tumors after complete resection]. Fang YJ; Zhang RX; Luo RZ; Ou QJ; Wan DS; Pan ZZ; Wu XJ Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Mar; 16(3):242-6. PubMed ID: 23536344 [TBL] [Abstract][Full Text] [Related]
10. Prognostic value of Ki-67 in stage I non-small-cell lung cancer: A meta-analysis involving 1931 patients. Xu J; Liu P; Da J; Hao J; Peng W; Sun G Pathol Res Pract; 2019 May; 215(5):855-860. PubMed ID: 30871912 [TBL] [Abstract][Full Text] [Related]
11. The abnormalities in the p53/p21WAF1 pathway have a significant role in the pathogenesis and progression of gastrointestinal stromal tumors. Chou YP; Lin JW; Wang CC; Chiu YC; Huang CC; Chuah SK; Tai MH; Yi LN; Lee CM; Changchien CS; Hu TH Oncol Rep; 2008 Jan; 19(1):49-56. PubMed ID: 18097575 [TBL] [Abstract][Full Text] [Related]
12. Prognostic value of different cut-off levels of Ki-67 in breast cancer: a systematic review and meta-analysis of 64,196 patients. Petrelli F; Viale G; Cabiddu M; Barni S Breast Cancer Res Treat; 2015 Oct; 153(3):477-91. PubMed ID: 26341751 [TBL] [Abstract][Full Text] [Related]
13. Ki-67 labelling index is related to the risk classification and prognosis of gastrointestinal stromal tumours: a retrospective study. Wang JP; Liu L; Li ZA; Wang Q; Wang XY; Lin J Gastroenterol Hepatol; 2021 Feb; 44(2):103-114. PubMed ID: 32718848 [TBL] [Abstract][Full Text] [Related]
14. [Roles of risk assessment and Ki-67 index in judging prognostic of gastrointestinal stromal tumors]. Liang YM; Li XH; Chen W Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(15):1041-5. PubMed ID: 18754437 [TBL] [Abstract][Full Text] [Related]
15. Exon 11 mutations, Ki67, and p16(INK4A) as predictors of prognosis in patients with GIST. Cerski MR; Pereira F; Matte US; Oliveira FH; Crusius FL; Waengertner LE; Osvaldt A; Fornari F; Meurer L Pathol Res Pract; 2011 Nov; 207(11):701-6. PubMed ID: 22024151 [TBL] [Abstract][Full Text] [Related]
16. Interobserver variability of mitotic index and utility of PHH3 for risk stratification in gastrointestinal stromal tumors. Alkhasawneh A; Reith JD; Toro TZ; Ayed AO; Lu X; George TJ; Duckworth LV Am J Clin Pathol; 2015 Mar; 143(3):385-92. PubMed ID: 25696796 [TBL] [Abstract][Full Text] [Related]